Posted On: 08/06/2014 11:32:11 AM
Post# of 45008
$MNKD Recent News
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:15 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Sue Chang
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - Russ Britt
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - Russ Britt
Stock futures pare gains after ADP 8:59 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:14 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:14 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind inks new insulin supply contract 7:11 a.m. Today - Seeking Alpha
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD 6:00 a.m. Aug. 4, 2014 - InvestorPlace.com
Jardiance achieves regulatory clearance 12:54 p.m. Aug. 1, 2014 - Seeking Alpha
'Mad Money' Lightning Round: No Fan of Peabody Energy 6:00 a.m. July 30, 2014 - TheStreet.com
Cramer's Lightning Round - Mannkind Needs A Partner (7/29/14) 5:26 a.m. July 30, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Looking at the Dark Side 8:05 p.m. July 29, 2014 - TheStreet.com
Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market 4:50 p.m. July 29, 2014 - GuruFocus.com
MannKind: Let It Dip A Bit More, Then Cover/Buy 12:55 p.m. July 28, 2014 - Seeking Alpha
5 Stocks With Crummy Sales Growth — HTS MITT UEC LPCN MNKD 4:15 a.m. July 28, 2014 - InvestorPlace.com
Mannkind Corporation: Safe Labeling, Incentivized Spirometry and Experts Votes of Confidence 5:59 p.m. July 25, 2014 - GuruFocus.com
MannKind: Why The Short Argument Is Shortsighted 2:18 p.m. July 25, 2014 - Seeking Alpha
MannKind Afrezza Partnership News Coming Within Weeks 11:30 a.m. July 25, 2014 - TheStreet.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook 3:47 a.m. July 24, 2014 - Zacks.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews 3:47 a.m. July 24, 2014 - Zacks.com
AFREZZA Is A Brilliant Technology Without A Compelling Marketing Story 4:20 p.m. July 23, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – INO CNC WCG MNKD 7:45 a.m. July 22, 2014 - InvestorPlace.com
5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise 9:53 a.m. July 21, 2014 - Seeking Alpha
Top Swing Trade Ideas for Monday July 21: Cliffs Natural Resources, MannKind, PolyOne 9:19 a.m. July 21, 2014 - TheStreet.com
5 Stocks With Bad Sales Growth — HTS MITT UEC LPCN MNKD 4:15 a.m. July 21, 2014 - InvestorPlace.com
Recent Tsunami of Insider Shares Purchased: A Prelude To Mannkind Partnership or Acquisition 10:22 p.m. July 19, 2014 - GuruFocus.com
MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014 5:00 p.m. Aug. 5, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver 9:31 a.m. July 1, 2014 - PR Newswire - PRF
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:02 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:02 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:01 a.m. April 17, 2014 - ACCESSWIRE
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:15 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Sue Chang
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - Russ Britt
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - Russ Britt
Stock futures pare gains after ADP 8:59 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:14 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:14 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind inks new insulin supply contract 7:11 a.m. Today - Seeking Alpha
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD 6:00 a.m. Aug. 4, 2014 - InvestorPlace.com
Jardiance achieves regulatory clearance 12:54 p.m. Aug. 1, 2014 - Seeking Alpha
'Mad Money' Lightning Round: No Fan of Peabody Energy 6:00 a.m. July 30, 2014 - TheStreet.com
Cramer's Lightning Round - Mannkind Needs A Partner (7/29/14) 5:26 a.m. July 30, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Looking at the Dark Side 8:05 p.m. July 29, 2014 - TheStreet.com
Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market 4:50 p.m. July 29, 2014 - GuruFocus.com
MannKind: Let It Dip A Bit More, Then Cover/Buy 12:55 p.m. July 28, 2014 - Seeking Alpha
5 Stocks With Crummy Sales Growth — HTS MITT UEC LPCN MNKD 4:15 a.m. July 28, 2014 - InvestorPlace.com
Mannkind Corporation: Safe Labeling, Incentivized Spirometry and Experts Votes of Confidence 5:59 p.m. July 25, 2014 - GuruFocus.com
MannKind: Why The Short Argument Is Shortsighted 2:18 p.m. July 25, 2014 - Seeking Alpha
MannKind Afrezza Partnership News Coming Within Weeks 11:30 a.m. July 25, 2014 - TheStreet.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook 3:47 a.m. July 24, 2014 - Zacks.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews 3:47 a.m. July 24, 2014 - Zacks.com
AFREZZA Is A Brilliant Technology Without A Compelling Marketing Story 4:20 p.m. July 23, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – INO CNC WCG MNKD 7:45 a.m. July 22, 2014 - InvestorPlace.com
5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise 9:53 a.m. July 21, 2014 - Seeking Alpha
Top Swing Trade Ideas for Monday July 21: Cliffs Natural Resources, MannKind, PolyOne 9:19 a.m. July 21, 2014 - TheStreet.com
5 Stocks With Bad Sales Growth — HTS MITT UEC LPCN MNKD 4:15 a.m. July 21, 2014 - InvestorPlace.com
Recent Tsunami of Insider Shares Purchased: A Prelude To Mannkind Partnership or Acquisition 10:22 p.m. July 19, 2014 - GuruFocus.com
MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014 5:00 p.m. Aug. 5, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver 9:31 a.m. July 1, 2014 - PR Newswire - PRF
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:02 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:02 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:01 a.m. April 17, 2014 - ACCESSWIRE
(0)
(0)
